# NON-DISCLOSURE AGREEMENT
## CAREMATCH AI HEALTHCARE PLATFORM

---

**THIS AGREEMENT** is made on this _____ day of _____________, 20___

**BETWEEN:**

**1. CAREMATCH AI LIMITED** (hereinafter referred to as "**the Company**" or "**Disclosing Party**"), a company incorporated under the laws of the Federal Republic of Nigeria with registered office at _________________________________, Nigeria

**AND**

**2. ________________________________** (hereinafter referred to as "**the Receiving Party**"), of _________________________________ (Please state full legal name, address, and registration details if a company/organization)

(Hereinafter individually referred to as a "**Party**" and collectively as the "**Parties**")

---

## RECITALS

**WHEREAS:**

**A.** The Company is developing, operating, and commercializing CareMatch AI, a comprehensive AI-powered healthcare ecosystem consisting of interconnected platforms including CareWebb (web application), CareMatch Mobile (mobile application), Clinic Bridge (clinic management software), and Hospital Management Platform (collectively referred to as "**the Platform**").

**B.** The Platform processes sensitive healthcare information, medical data, patient records, proprietary artificial intelligence algorithms, business strategies, technical specifications, and other confidential information related to healthcare delivery in Nigeria, the United Kingdom, and across Africa.

**C.** The Receiving Party may be an employee, contractor, consultant, partner, investor, potential investor, service provider, business partner, or other stakeholder who will have access to Confidential Information (as defined below) belonging to the Company.

**D.** The Company wishes to disclose certain Confidential Information to the Receiving Party for the Purpose (as defined below), and the Receiving Party has agreed to receive and maintain such information in strict confidence in accordance with the terms of this Agreement.

**E.** Both Parties acknowledge that this Agreement is necessary to protect the legitimate business interests of the Company while ensuring compliance with applicable data protection and healthcare regulations in Nigeria and the United Kingdom.

**NOW THEREFORE,** in consideration of the mutual covenants and agreements contained herein, and for other good and valuable consideration (the receipt and sufficiency of which are hereby acknowledged), the Parties hereby agree as follows:

---

## 1. DEFINITIONS AND INTERPRETATION

**1.1** In this Agreement, unless the context otherwise requires, the following terms shall have the meanings assigned to them below:

**"Affiliate"** means any entity that directly or indirectly controls, is controlled by, or is under common control with a Party, where "control" means ownership of more than 50% of the voting securities or beneficial interest in such entity.

**"Applicable Data Protection Laws"** means all applicable laws, regulations, and regulatory requirements relating to the processing of personal data and privacy, including but not limited to:
- The Nigeria Data Protection Act (NDPA) 2023
- The Nigeria Data Protection Regulation (NDPR) 2019 (as applicable)
- The National Health Act 2014 (Nigeria)
- The UK General Data Protection Regulation (UK GDPR)
- The UK Data Protection Act 2018
- The Health Insurance Portability and Accountability Act (HIPAA) where applicable
- Any successor or replacement legislation

**"Business Day"** means any day other than a Saturday, Sunday, or public holiday in Nigeria or the United Kingdom.

**"Confidential Information"** means all information, whether written, oral, electronic, visual, or in any other form, disclosed by or on behalf of the Disclosing Party to the Receiving Party, whether before, on, or after the date of this Agreement, which relates to the business, operations, technology, intellectual property, or affairs of the Disclosing Party, including but not limited to:

(a) **Healthcare and Medical Information:**
   - Patient health records, medical histories, and health status information
   - Consultation records, treatment plans, and clinical data
   - Health analytics, disease patterns, and epidemiological data
   - Mental health assessments and counseling records
   - NAFDAC drug verification database and pharmaceutical information
   - Hospital and clinic operational data
   - Healthcare provider information and credentials

(b) **Technical and Proprietary Information:**
   - Artificial Intelligence algorithms, models, training data, and machine learning parameters
   - Source code, object code, software architecture, and technical specifications
   - Platform design, user interface designs, and user experience flows
   - Database schemas, data structures, and system architectures
   - API specifications, integration protocols, and technical documentation
   - Offline-first technology implementation and synchronization mechanisms
   - Multi-language natural language processing systems
   - Security protocols, encryption methods, and authentication systems

(c) **Business and Commercial Information:**
   - Business plans, strategies, models, and forecasts
   - Marketing strategies, user acquisition plans, and growth tactics
   - Pricing strategies, revenue models, and financial projections
   - Partnership agreements, supplier contracts, and vendor relationships
   - Customer lists, user data, and engagement metrics
   - Market research, competitive analyses, and industry insights
   - Investment terms, funding rounds, and capitalization tables

(d) **Intellectual Property:**
   - Patents, patent applications, and invention disclosures
   - Trademarks, trade names, logos, and brand guidelines
   - Copyrights, trade secrets, and know-how
   - Proprietary methodologies, processes, and techniques
   - Research and development projects and outcomes

(e) **Financial Information:**
   - Financial statements, budgets, and cash flow projections
   - Revenue reports, expense breakdowns, and profit margins
   - Investment agreements and funding documentation
   - Tax returns, audit reports, and accounting records
   - Banking information and financial transactions

(f) **Personal Data:**
   - Employee information, compensation details, and HR records
   - User personal identifiable information (PII)
   - Health-related personal data as defined under NDPA 2023 and UK GDPR

**"Controller"**, **"Processor"**, **"Data Subject"**, **"Personal Data"**, and **"Processing"** shall have the meanings ascribed to them in the Applicable Data Protection Laws.

**"Effective Date"** means the date first written above or the date of first disclosure of Confidential Information, whichever is earlier.

**"Health Information"** means any information relating to the physical or mental health of an individual, including:
- Medical history, diagnoses, and treatment information
- Genetic and biometric data
- Healthcare provider notes and assessments
- Prescription and medication records
- Laboratory test results and medical imaging
- Health insurance information

**"Intellectual Property Rights"** or **"IPR"** means all intellectual property rights wherever in the world, whether registerable or unregisterable, registered or unregistered, including any application or right of application for such rights, including but not limited to patents, copyrights, database rights, design rights, trademarks, service marks, trade names, domain names, trade secrets, know-how, and confidential information.

**"Purpose"** means:
[*To be specified based on the relationship - examples below:*]
- Employment or engagement as [Job Title/Role]
- Evaluation of potential business partnership or collaboration
- Investment due diligence and evaluation
- Provision of [specific services] to the Company
- Development and enhancement of the Platform
- [Other specific purpose to be inserted]

**1.2** Unless the context otherwise requires:
(a) References to clauses and schedules are to clauses of and schedules to this Agreement
(b) Headings are for convenience only and do not affect interpretation
(c) Words importing the singular include the plural and vice versa
(d) Words importing gender include all genders
(e) References to "writing" or "written" include email and other electronic communication
(f) References to persons include individuals, corporations, partnerships, and unincorporated associations
(g) References to legislation include any amendment, re-enactment, or consolidation

---

## 2. SCOPE AND PURPOSE OF DISCLOSURE

**2.1 Purpose of Disclosure**

The Disclosing Party agrees to disclose Confidential Information to the Receiving Party solely for the Purpose specified in Clause 1.1 and for no other purpose whatsoever without the prior written consent of the Disclosing Party.

**2.2 Limitation of Use**

The Receiving Party shall not use the Confidential Information for any purpose other than the Purpose, including but not limited to:
(a) Commercial exploitation for the Receiving Party's own benefit
(b) Development of competing products or services
(c) Disclosure to competitors of the Disclosing Party
(d) Any purpose that would harm the legitimate business interests of the Disclosing Party

**2.3 No License or Transfer**

Nothing in this Agreement shall be construed as granting to the Receiving Party any license, rights, or interest in the Confidential Information or any Intellectual Property Rights of the Disclosing Party, except the limited right to use the Confidential Information for the Purpose in accordance with this Agreement.

---

## 3. OBLIGATIONS OF THE RECEIVING PARTY

**3.1 Duty of Confidentiality**

The Receiving Party hereby undertakes and agrees to:

(a) Keep the Confidential Information strictly confidential and secret
(b) Not disclose, divulge, reveal, report, publish, transfer, or otherwise communicate the Confidential Information, in whole or in part, to any third party without the prior written consent of the Disclosing Party
(c) Use the Confidential Information solely for the Purpose and not for any other purpose
(d) Take all necessary and reasonable precautions to prevent unauthorized disclosure, copying, or use of the Confidential Information
(e) Comply with all Applicable Data Protection Laws when processing any Confidential Information that constitutes Personal Data

**3.2 Standard of Care**

The Receiving Party shall protect the Confidential Information with at least the same degree of care that it uses to protect its own confidential information of a similar nature, but in no event less than reasonable care. This includes implementing and maintaining appropriate technical and organizational measures in accordance with Applicable Data Protection Laws.

**3.3 Security Measures**

Without limiting the generality of Clauses 3.1 and 3.2, the Receiving Party shall implement and maintain the following minimum security measures:

(a) **Physical Security:**
   - Secure storage of all physical documents containing Confidential Information in locked facilities
   - Controlled access to areas where Confidential Information is stored or processed
   - Secure disposal procedures for physical materials containing Confidential Information

(b) **Technical Security:**
   - Encryption of electronic Confidential Information both in transit and at rest
   - Use of secure passwords, multi-factor authentication, and access control mechanisms
   - Installation and regular updating of antivirus, anti-malware, and firewall software
   - Regular security audits and vulnerability assessments
   - Secure backup and disaster recovery procedures
   - Network security measures including VPNs for remote access

(c) **Organizational Security:**
   - Written information security policies and procedures
   - Regular security awareness training for personnel with access to Confidential Information
   - Incident response and breach notification procedures
   - Regular review and updating of security measures

(d) **Healthcare-Specific Security (where applicable):**
   - Compliance with National Health Act 2014 requirements for health facility data protection
   - Adherence to NDPA 2023 requirements for processing health-related sensitive personal data
   - Implementation of UK GDPR Article 9 safeguards for processing special category data
   - Compliance with any applicable clinical governance and patient safety requirements

**3.4 Limited Disclosure**

The Receiving Party may disclose Confidential Information only to those of its employees, officers, directors, agents, contractors, professional advisors, and Affiliates (collectively "**Representatives**") who:

(a) Have a legitimate need to know the Confidential Information for the Purpose
(b) Have been informed of the confidential nature of the information
(c) Are bound by confidentiality obligations at least as restrictive as those contained in this Agreement, whether by written agreement, professional duty, or applicable law

The Receiving Party shall be responsible and liable for any breach of this Agreement by its Representatives as if such breach were committed by the Receiving Party itself.

**3.5 No Reverse Engineering**

The Receiving Party shall not, and shall ensure that its Representatives do not:

(a) Reverse engineer, decompile, disassemble, or otherwise attempt to derive the source code or underlying algorithms of any software or AI models disclosed as Confidential Information
(b) Modify, adapt, translate, or create derivative works based on the Confidential Information
(c) Remove, alter, or obscure any proprietary notices, labels, or marks on the Confidential Information

**3.6 No Unauthorized Copying**

The Receiving Party shall not copy, reproduce, or create derivative works from the Confidential Information except as strictly necessary for the Purpose and with the prior written approval of the Disclosing Party. Any copies made shall:

(a) Be clearly marked as confidential
(b) Be subject to the same restrictions as the original Confidential Information
(c) Be returned or destroyed in accordance with Clause 8 upon termination of this Agreement

**3.7 Return or Destruction of Confidential Information**

Upon the earlier of: (i) completion of the Purpose; (ii) termination of this Agreement; (iii) written request by the Disclosing Party; or (iv) when the Receiving Party no longer needs the Confidential Information for the Purpose, the Receiving Party shall, at the Disclosing Party's option:

(a) Promptly return to the Disclosing Party all Confidential Information in its possession or control, including all copies, notes, extracts, summaries, and derivatives; or
(b) Permanently and securely destroy all such materials and provide a written certificate of destruction signed by an authorized officer

**Provided that** the Receiving Party may retain one copy of the Confidential Information solely for legal and regulatory compliance purposes, subject to continued confidentiality obligations.

---

## 4. EXCLUSIONS FROM CONFIDENTIAL INFORMATION

**4.1** The obligations of confidentiality set out in this Agreement shall not apply to any information that the Receiving Party can demonstrate:

(a) **Public Domain:** Was in the public domain at the time of disclosure or subsequently becomes part of the public domain through no fault, breach, or action of the Receiving Party;

(b) **Prior Knowledge:** Was already lawfully known to the Receiving Party prior to disclosure by the Disclosing Party, as evidenced by written records dated before the disclosure;

(c) **Third Party Disclosure:** Was lawfully received by the Receiving Party from a third party who had the legal right to disclose such information and who did not impose confidentiality obligations on the Receiving Party;

(d) **Independent Development:** Was independently developed by the Receiving Party without reference to or use of the Confidential Information, as evidenced by written records;

(e) **Legally Required Disclosure:** Is required to be disclosed by applicable law, regulation, court order, governmental authority, or regulatory body, **provided that** the Receiving Party:
   - Gives the Disclosing Party prompt written notice of such requirement (to the extent legally permitted)
   - Cooperates with the Disclosing Party in seeking a protective order or other appropriate remedy
   - Discloses only the minimum information required
   - Uses reasonable efforts to obtain confidential treatment for any information so disclosed

**4.2 Whistleblowing and Legal Rights**

Notwithstanding any other provision of this Agreement, nothing in this Agreement shall:

(a) Prevent the Receiving Party from making a protected disclosure under:
   - The Public Interest Disclosure Act 1998 (UK)
   - The Whistleblower Protection Bill (Nigeria) when enacted
   - Any other applicable whistleblowing legislation

(b) Prevent the Receiving Party from:
   - Reporting a crime or suspected criminal activity to law enforcement authorities
   - Cooperating with regulatory investigations or law enforcement agencies
   - Disclosing information to the Nigeria Data Protection Commission (NDPC), UK Information Commissioner's Office (ICO), or other relevant regulatory authorities
   - Seeking legal advice from qualified legal professionals bound by professional duties of confidentiality
   - Making complaints about workplace harassment, discrimination, or other unlawful conduct

(c) Be used to conceal:
   - Fraud, corruption, or other criminal activity
   - Regulatory breaches or violations of law
   - Health and safety risks or hazards
   - Environmental damage or violations
   - Professional misconduct or malpractice

**4.3** The burden of proof for establishing that information falls within any of the exclusions in Clause 4.1 shall rest with the Receiving Party.

---

## 5. DATA PROTECTION COMPLIANCE

**5.1 Compliance with Data Protection Laws**

Both Parties acknowledge and agree that:

(a) They shall at all times comply with their respective obligations under Applicable Data Protection Laws
(b) The Disclosing Party shall remain the Data Controller of any Personal Data disclosed as Confidential Information unless otherwise agreed in writing
(c) Where the Receiving Party processes Personal Data on behalf of the Disclosing Party, the Receiving Party shall act as a Data Processor and shall comply with the data processing requirements set out in this Clause 5

**5.2 Data Processing Terms (Where Receiving Party is a Processor)**

Where the Receiving Party processes Personal Data on behalf of the Disclosing Party, the Receiving Party shall:

(a) Process the Personal Data only on documented instructions from the Disclosing Party, including with regard to transfers of Personal Data outside Nigeria or the United Kingdom
(b) Ensure that persons authorized to process the Personal Data are subject to appropriate confidentiality obligations
(c) Implement appropriate technical and organizational measures to ensure a level of security appropriate to the risk, including but not limited to:
   - Pseudonymization and encryption of Personal Data
   - Ability to ensure ongoing confidentiality, integrity, availability, and resilience of processing systems
   - Ability to restore availability and access to Personal Data in a timely manner in the event of a physical or technical incident
   - Processes for regularly testing, assessing, and evaluating the effectiveness of security measures

(d) Not engage another processor (sub-processor) without prior written authorization from the Disclosing Party
(e) Assist the Disclosing Party in ensuring compliance with data subject rights under Applicable Data Protection Laws
(f) Assist the Disclosing Party in meeting its obligations regarding security of processing, breach notifications, and data protection impact assessments
(g) At the choice of the Disclosing Party, delete or return all Personal Data after the end of the provision of services, and delete existing copies unless retention is required by applicable law
(h) Make available to the Disclosing Party all information necessary to demonstrate compliance with data processing obligations

**5.3 Health Information - Special Category Data**

The Parties acknowledge that Health Information constitutes "sensitive personal data" under Nigerian law and "special category data" under UK GDPR. Where the Receiving Party processes Health Information, it shall:

(a) Ensure that processing is necessary and has a lawful basis under Article 9(2) of UK GDPR and Section 29 of NDPA 2023
(b) Implement enhanced security measures appropriate to the sensitivity of Health Information
(c) Ensure that access to Health Information is limited to healthcare professionals or other authorized personnel with a legitimate need to know
(d) Comply with confidentiality requirements under the National Health Act 2014
(e) Ensure that any disclosure of Health Information is in accordance with applicable healthcare privacy laws and professional codes of conduct
(f) Maintain detailed records of all processing activities involving Health Information

**5.4 Data Breach Notification**

In the event of a Personal Data breach involving Confidential Information, the Receiving Party shall:

(a) Notify the Disclosing Party without undue delay and in any event within 24 hours of becoming aware of the breach
(b) Provide the following information (to the extent available):
   - Nature of the breach, including categories and approximate number of Data Subjects affected
   - Categories and approximate number of Personal Data records concerned
   - Likely consequences of the breach
   - Measures taken or proposed to address the breach and mitigate its adverse effects

(c) Cooperate with the Disclosing Party in investigating the breach and implementing remedial measures
(d) Not make any public statements or notifications regarding the breach without prior written approval from the Disclosing Party, except as required by law

**5.5 Data Protection Officer**

To the extent required by Applicable Data Protection Laws, each Party shall appoint a Data Protection Officer and provide the contact details to the other Party.

**5.6 Cross-Border Data Transfers**

If the Receiving Party transfers Confidential Information containing Personal Data outside Nigeria or the United Kingdom, it shall:

(a) Ensure that such transfer is permitted under Applicable Data Protection Laws
(b) Implement appropriate safeguards, which may include:
   - Standard contractual clauses approved by the Nigeria Data Protection Commission or the European Commission/UK Information Commissioner's Office
   - Binding corporate rules
   - Adherence to approved certification mechanisms
   - Adequacy decisions by relevant authorities

(c) Obtain prior written consent from the Disclosing Party before making any such transfer

---

## 6. INTELLECTUAL PROPERTY RIGHTS

**6.1 Ownership**

All Confidential Information, including all Intellectual Property Rights therein, shall remain the sole and exclusive property of the Disclosing Party. No transfer of ownership or license is granted to the Receiving Party except as expressly set forth in this Agreement.

**6.2 No Rights to IP**

The Receiving Party acknowledges and agrees that:

(a) This Agreement does not grant the Receiving Party any rights to the Disclosing Party's Intellectual Property Rights
(b) All patents, copyrights, trademarks, trade secrets, and other proprietary rights in the Confidential Information remain with the Disclosing Party
(c) The Receiving Party shall not apply for or register any Intellectual Property Rights that incorporate, are based on, or are derived from the Confidential Information

**6.3 Improvements and Derivative Works**

Any improvements, modifications, enhancements, or derivative works created by the Receiving Party based on or incorporating the Confidential Information shall be the sole property of the Disclosing Party, and the Receiving Party hereby assigns all rights, title, and interest in such works to the Disclosing Party.

**6.4 Trade Marks**

The Receiving Party shall not use any trademarks, service marks, trade names, logos, or other proprietary designations of the Disclosing Party without prior written permission. This includes the "CareMatch AI" name, logos, and all related branding.

---

## 7. TERM AND TERMINATION

**7.1 Effective Date and Term**

This Agreement shall come into force on the Effective Date and shall continue in full force and effect for a period of **five (5) years** from the Effective Date, unless earlier terminated in accordance with this Clause 7.

**7.2 Termination**

(a) **Termination by Mutual Consent:** This Agreement may be terminated at any time by mutual written consent of the Parties.

(b) **Termination by Either Party:** Either Party may terminate this Agreement by giving not less than **thirty (30) days'** prior written notice to the other Party.

(c) **Termination for Breach:** Either Party may terminate this Agreement with immediate effect by written notice if:
   - The other Party commits a material breach of this Agreement and fails to remedy such breach within **fourteen (14) Business Days** of receiving written notice specifying the breach
   - The other Party becomes insolvent, enters into liquidation, administration, receivership, or similar proceedings
   - The other Party ceases to carry on business

**7.3 Survival**

Notwithstanding termination or expiration of this Agreement for any reason:

(a) The obligations of confidentiality under this Agreement shall survive and continue for a period of **ten (10) years** from the date of termination or expiration, or for as long as the information remains confidential, whichever is longer.

(b) The following Clauses shall survive indefinitely: Clause 5 (Data Protection Compliance), Clause 6 (Intellectual Property Rights), Clause 8 (Return or Destruction of Information), Clause 9 (Remedies and Enforcement), Clause 11 (Indemnification), Clause 14 (Limitation of Liability), and Clause 16 (Governing Law and Jurisdiction).

(c) For Health Information, the confidentiality obligations shall survive in perpetuity in accordance with medical confidentiality requirements.

---

## 8. RETURN OR DESTRUCTION OF CONFIDENTIAL INFORMATION

**8.1** Upon termination or expiration of this Agreement, or at any time upon the Disclosing Party's written request, the Receiving Party shall, within **ten (10) Business Days**:

(a) Return to the Disclosing Party all Confidential Information in its possession or control, including all documents, materials, copies, notes, analyses, compilations, studies, or other materials containing or reflecting Confidential Information; or

(b) At the Disclosing Party's written election, securely destroy all such materials using industry-standard methods that prevent recovery or reconstruction; and

(c) Certify in writing to the Disclosing Party, signed by an authorized officer, that all Confidential Information has been returned or destroyed in accordance with this Clause

**8.2 Exceptions**

The Receiving Party may retain:

(a) One copy of the Confidential Information as required by applicable law or regulation, or for legal and compliance purposes, subject to continued confidentiality obligations
(b) Confidential Information stored on automatic backup systems, provided that such information is permanently deleted in accordance with the Receiving Party's standard backup retention policies and remains subject to confidentiality obligations

---

## 9. REMEDIES AND ENFORCEMENT

**9.1 Breach of Agreement**

The Receiving Party acknowledges and agrees that:

(a) The Confidential Information is valuable, unique, and proprietary to the Disclosing Party
(b) Any breach or threatened breach of this Agreement will cause irreparable harm and injury to the Disclosing Party
(c) Monetary damages alone would be an inadequate remedy for any such breach

**9.2 Injunctive Relief**

In addition to any other rights and remedies available at law or in equity, the Disclosing Party shall be entitled to seek:

(a) Immediate injunctive relief, specific performance, or other equitable remedies to prevent or restrain any actual or threatened breach of this Agreement, without the requirement to:
   - Post a bond or other security
   - Prove actual damages or irreparable harm (which is presumed)
   - Exhaust administrative remedies

(b) Such relief from any court of competent jurisdiction in Nigeria or the United Kingdom

**9.3 Remedies Cumulative**

All rights and remedies provided in this Agreement are cumulative and not exclusive, and the exercise of any right or remedy shall not preclude the exercise of any other rights or remedies that may be available to the Disclosing Party at law or in equity.

**9.4 Damages**

Without limiting the Disclosing Party's right to seek injunctive relief, in the event of a breach by the Receiving Party, the Receiving Party shall be liable for:

(a) **Direct Damages:** All actual damages suffered by the Disclosing Party, including but not limited to:
   - Loss of competitive advantage
   - Damage to reputation and goodwill
   - Lost profits and business opportunities
   - Costs of remedial measures
   - Legal fees and costs of enforcement

(b) **Consequential Damages:** Where applicable, consequential damages including loss of business, revenue, or anticipated savings

(c) **Accounting for Profits:** Any profits obtained by the Receiving Party or any third party as a result of the breach

(d) **Regulatory Fines and Penalties:** Any fines, penalties, or sanctions imposed by regulatory authorities as a result of the breach

**9.5 Data Protection Remedies**

In the event of a breach of Clause 5 (Data Protection Compliance), the Disclosing Party may also:

(a) Report the breach to the Nigeria Data Protection Commission (NDPC) and/or the UK Information Commissioner's Office (ICO)
(b) Claim compensation for material or non-material damage suffered by Data Subjects as a result of the breach
(c) Seek administrative fines and penalties as provided under NDPA 2023 and UK GDPR

**9.6 Healthcare-Specific Remedies**

In the event of a breach involving Health Information, the Disclosing Party may:

(a) Report the breach to the Federal Ministry of Health (Nigeria) and/or relevant UK healthcare regulators
(b) Claim compensation for harm to patients or Data Subjects
(c) Seek sanctions under the National Health Act 2014 or other applicable healthcare legislation

---

## 10. NO WARRANTIES

**10.1** ALL CONFIDENTIAL INFORMATION IS PROVIDED "AS IS" AND "AS AVAILABLE" WITHOUT ANY WARRANTY OF ANY KIND, EXPRESS OR IMPLIED.

**10.2** The Disclosing Party makes no representations or warranties regarding:
(a) The accuracy, completeness, or reliability of the Confidential Information
(b) The fitness of the Confidential Information for any particular purpose
(c) That the use of the Confidential Information will not infringe any third-party rights
(d) The merchantability or quality of any products or services described in the Confidential Information

**10.3** The Receiving Party acknowledges that it relies on the Confidential Information at its own risk and shall conduct its own independent investigation and analysis.

---

## 11. INDEMNIFICATION

**11.1 Indemnity by Receiving Party**

The Receiving Party hereby agrees to indemnify, defend, and hold harmless the Disclosing Party, its Affiliates, and their respective officers, directors, employees, agents, successors, and assigns (collectively "**Indemnified Parties**") from and against any and all:

(a) Claims, demands, actions, suits, or proceedings ("**Claims**")
(b) Losses, damages, liabilities, costs, and expenses (including reasonable legal fees and costs) ("**Losses**")

Arising out of or relating to:
- Any breach of this Agreement by the Receiving Party or its Representatives
- Unauthorized use or disclosure of Confidential Information
- Breach of Applicable Data Protection Laws in relation to Confidential Information
- Any violation of third-party rights resulting from the Receiving Party's use of Confidential Information
- Any regulatory action or investigation arising from the Receiving Party's breach

**11.2 Defense of Claims**

The Receiving Party shall, at its own expense:
(a) Promptly assume the defense of any Claim upon written notice from an Indemnified Party
(b) Engage competent legal counsel reasonably acceptable to the Disclosing Party
(c) Keep the Disclosing Party fully informed of the progress of the defense
(d) Not settle or compromise any Claim without the prior written consent of the Disclosing Party

**11.3 Cooperation**

The Indemnified Parties shall:
(a) Provide prompt written notice of any Claim
(b) Cooperate reasonably with the Receiving Party in the defense of the Claim
(c) Permit the Receiving Party to control the defense and settlement of the Claim, subject to Clause 11.2(d)

---

## 12. NO OBLIGATION TO DISCLOSE

**12.1** Nothing in this Agreement shall obligate the Disclosing Party to disclose any particular information to the Receiving Party.

**12.2** The Disclosing Party reserves the right, in its sole discretion, to:
(a) Determine what information to disclose
(b) Refuse to disclose any information
(c) Withdraw any information previously disclosed

---

## 13. NO OBLIGATION TO PROCEED

**13.1** The Parties acknowledge and agree that:

(a) This Agreement does not create any obligation for the Parties to proceed with any business relationship, transaction, or collaboration
(b) Neither Party shall have any liability to the other for choosing not to proceed with any proposed relationship or transaction
(c) This Agreement does not create any partnership, joint venture, agency, employment, or fiduciary relationship between the Parties

**13.2** Each Party retains the absolute discretion to pursue or reject any business opportunities discussed in connection with the Purpose.

---

## 14. LIMITATION OF LIABILITY

**14.1 No Consequential Damages (Subject to Exceptions)**

EXCEPT in cases of:
- Fraud or fraudulent misrepresentation
- Willful breach or gross negligence
- Breach of data protection obligations under Clause 5
- Breach involving Health Information
- Death or personal injury caused by negligence
- Any other liability that cannot be excluded or limited by law

Neither Party shall be liable to the other for any indirect, incidental, consequential, special, or punitive damages, including loss of profits, revenue, data, or business opportunities, even if advised of the possibility of such damages.

**14.2 Cap on Liability (Subject to Exceptions)**

Subject to Clause 14.1, the total aggregate liability of either Party arising out of or relating to this Agreement shall not exceed:

- For the Receiving Party: The greater of (i) [INSERT AMOUNT: e.g., £1,000,000 / ₦500,000,000] or (ii) actual damages proven by the Disclosing Party
- For the Disclosing Party: [INSERT AMOUNT: e.g., £100,000 / ₦50,000,000]

**14.3 Exceptions**

The limitations in Clauses 14.1 and 14.2 shall not apply to:
(a) Liability for breach of confidentiality obligations
(b) Liability for breach of data protection obligations
(c) Indemnification obligations under Clause 11
(d) Liability for intellectual property infringement
(e) Regulatory fines and penalties
(f) Any liability that cannot be limited or excluded by applicable law

---

## 15. GENERAL PROVISIONS

**15.1 Entire Agreement**

This Agreement constitutes the entire agreement between the Parties concerning the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations, and discussions, whether oral or written, between the Parties relating to such subject matter.

**15.2 Amendment and Modification**

No amendment, modification, or waiver of any provision of this Agreement shall be effective unless:
(a) Made in writing
(b) Signed by duly authorized representatives of both Parties
(c) Expressly stating the intention to amend this Agreement

**15.3 Waiver**

(a) No waiver of any provision of this Agreement shall be deemed or shall constitute a waiver of any other provision
(b) No waiver shall constitute a continuing waiver unless expressly stated
(c) No failure or delay by either Party in exercising any right or remedy shall constitute a waiver of that right or remedy
(d) No single or partial exercise of any right or remedy shall preclude further exercise of that right or remedy

**15.4 Severability**

If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction:
(a) Such provision shall be deemed modified to the minimum extent necessary to make it valid, legal, and enforceable
(b) If such modification is not possible, the provision shall be severed from this Agreement
(c) The remaining provisions shall continue in full force and effect
(d) The Parties shall negotiate in good faith to replace the invalid provision with a valid provision that achieves the original intent

**15.5 Assignment**

(a) The Receiving Party shall not assign, transfer, delegate, or otherwise dispose of any of its rights or obligations under this Agreement without the prior written consent of the Disclosing Party
(b) Any purported assignment in violation of this Clause shall be null and void
(c) The Disclosing Party may assign this Agreement to any Affiliate or in connection with a merger, acquisition, reorganization, or sale of all or substantially all of its assets
(d) This Agreement shall be binding upon and inure to the benefit of the Parties and their respective permitted successors and assigns

**15.6 No Third-Party Beneficiaries**

This Agreement is for the sole benefit of the Parties and their permitted successors and assigns, and nothing in this Agreement shall create or be deemed to create any third-party beneficiary rights in any person or entity not a party to this Agreement, except for the Indemnified Parties under Clause 11.

**15.7 Relationship of Parties**

Nothing in this Agreement shall be construed to create a partnership, joint venture, agency, employment, or fiduciary relationship between the Parties. Neither Party has the authority to bind or commit the other Party in any manner whatsoever.

**15.8 Independent Legal Advice**

Each Party acknowledges that:
(a) It has had the opportunity to seek independent legal advice before entering into this Agreement
(b) It has either sought such advice or chosen not to do so
(c) It fully understands its rights and obligations under this Agreement

**15.9 Counterparts**

This Agreement may be executed in any number of counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart by email (PDF) or other electronic means shall be equally effective as delivery of a manually executed counterpart.

**15.10 Further Assurances**

Each Party agrees to execute and deliver such further documents and instruments and to take such other actions as may be reasonably necessary or desirable to carry out the provisions and purposes of this Agreement.

**15.11 Language**

This Agreement is executed in the English language. If this Agreement is translated into any other language, the English language version shall prevail in case of any conflict or inconsistency.

**15.12 Notices**

**15.12.1** All notices, requests, consents, claims, demands, waivers, and other communications under this Agreement shall be in writing and shall be deemed to have been given:

(a) When delivered by hand: upon delivery
(b) When sent by registered or certified mail, return receipt requested: five (5) Business Days after mailing
(c) When sent by email: on the first Business Day after transmission, provided a read receipt or acknowledgment is received
(d) When sent by courier: upon delivery

**15.12.2** Notices shall be sent to the addresses set forth below or to such other address as either Party may specify in writing:

**For the Company:**
CareMatch AI Limited
[Insert Physical Address]
Email: [Insert Email]
Attention: [Insert Name and Title]

**For the Receiving Party:**
[Insert Name]
[Insert Physical Address]
Email: [Insert Email]
Attention: [Insert Name and Title]

**15.13 Force Majeure**

Neither Party shall be liable for any failure or delay in performing its obligations under this Agreement to the extent that such failure or delay is caused by circumstances beyond its reasonable control, including but not limited to acts of God, war, terrorism, civil unrest, labor disputes, epidemics, pandemics, governmental actions, or failures of telecommunications or internet services (**"Force Majeure Event"**).

The affected Party shall:
(a) Promptly notify the other Party of the Force Majeure Event
(b) Use reasonable efforts to mitigate the effects of the Force Majeure Event
(c) Resume performance as soon as reasonably practicable

If a Force Majeure Event continues for more than **ninety (90) days**, either Party may terminate this Agreement upon written notice to the other Party.

**15.14 Costs and Expenses**

Each Party shall bear its own costs and expenses incurred in connection with the negotiation, preparation, execution, and performance of this Agreement, unless otherwise expressly provided herein.

**15.15 Time of the Essence**

Time shall be of the essence with respect to all obligations under this Agreement.

---

## 16. GOVERNING LAW AND JURISDICTION

**16.1 Governing Law - Dual Jurisdiction**

This Agreement and any dispute or claim arising out of or in connection with it or its subject matter or formation (including non-contractual disputes or claims) shall be governed by and construed in accordance with:

(a) **The laws of the Federal Republic of Nigeria**, including but not limited to:
   - Nigerian Contract Law
   - The Evidence Act, 2011
   - The Companies and Allied Matters Act (CAMA), 2020
   - The Nigeria Data Protection Act (NDPA), 2023
   - The National Health Act, 2014
   - The Labour Act
   - Any other applicable Nigerian legislation

**AND**

(b) **The laws of England and Wales**, including but not limited to:
   - The UK General Data Protection Regulation (UK GDPR)
   - The Data Protection Act, 2018
   - The Public Interest Disclosure Act, 1998
   - Any other applicable UK legislation

**16.2 Conflict Resolution**

In the event of any conflict between Nigerian law and UK law:
(a) With respect to matters concerning Nigerian operations, Nigerian parties, or activities occurring in Nigeria, Nigerian law shall prevail
(b) With respect to matters concerning UK operations, UK parties, or activities occurring in the UK, UK law shall prevail
(c) With respect to data protection matters, the stricter standard shall apply to ensure maximum protection of Personal Data

**16.3 Jurisdiction - Nigerian Courts**

Subject to Clause 16.5 (Arbitration), the Parties irrevocably agree that the courts of Nigeria shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this Agreement or its subject matter or formation (including non-contractual disputes or claims).

Without prejudice to the above, the Disclosing Party may also seek injunctive relief or enforce this Agreement in any court of competent jurisdiction, including the courts of England and Wales or any other jurisdiction where a breach has occurred or is threatened.

**16.4 Submission to Jurisdiction**

Each Party irrevocably:
(a) Submits to the jurisdiction of the Nigerian courts for the purposes of any proceedings
(b) Waives any objection to proceedings in such courts on the grounds of venue or on the grounds that the proceedings have been brought in an inconvenient forum
(c) Agrees that a judgment or order of a Nigerian court shall be conclusive and binding and may be enforced in any other jurisdiction

**16.5 Alternative Dispute Resolution**

**16.5.1 Negotiation**

In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, or the breach, termination, or invalidity thereof (**"Dispute"**), the Parties shall first attempt to resolve the Dispute through good faith negotiations between senior executives of each Party within **twenty-one (21) days** of written notice of the Dispute.

**16.5.2 Mediation**

If the Dispute cannot be resolved through negotiation within the time period specified above, the Parties shall attempt to settle it by mediation in accordance with:
- The Lagos Court of Arbitration (LCA) Mediation Rules; or
- The Centre for Effective Dispute Resolution (CEDR) Model Mediation Procedure

The mediation shall be conducted in Lagos, Nigeria, or London, United Kingdom, as mutually agreed by the Parties.

**16.5.3 Arbitration**

If the Dispute cannot be resolved through mediation within **sixty (60) days** of commencement of mediation, or if either Party refuses to participate in mediation, the Dispute shall be finally resolved by arbitration as follows:

(a) **Arbitration Rules:** The arbitration shall be conducted in accordance with:
   - The Arbitration and Mediation Act, 2023 (Nigeria); or
   - The Arbitration Act 1996 (UK)
   As determined by the Parties or, failing agreement, as determined by the arbitral tribunal

(b) **Number of Arbitrators:** Three (3) arbitrators
   - Each Party shall appoint one arbitrator
   - The two party-appointed arbitrators shall appoint a third arbitrator who shall act as chairman

(c) **Seat of Arbitration:**
   - Lagos, Nigeria; or
   - London, United Kingdom
   As mutually agreed by the Parties or, failing agreement, as determined by the arbitral institution

(d) **Language:** English

(e) **Arbitral Institution:**
   - Lagos Court of Arbitration (LCA); or
   - London Court of International Arbitration (LCIA)
   As mutually agreed by the Parties

(f) **Governing Law:** The arbitration shall be governed by the substantive law set out in Clause 16.1

(g) **Confidentiality:** The arbitration proceedings, including all submissions, evidence, and awards, shall be kept strictly confidential

(h) **Finality:** The award of the arbitral tribunal shall be final and binding on the Parties and may be enforced in any court of competent jurisdiction

**16.5.4 Interim Relief**

Nothing in this Clause 16.5 shall prevent either Party from seeking interim or injunctive relief from a court of competent jurisdiction pending resolution of the Dispute through negotiation, mediation, or arbitration.

**16.5.5 Costs**

The costs of any mediation or arbitration shall be borne equally by the Parties, unless the mediator or arbitral tribunal determines otherwise. Each Party shall bear its own legal costs and expenses.

**16.6 Service of Process**

Each Party consents to service of process in any legal proceeding by:
(a) Personal delivery
(b) Registered or certified mail to the address specified in Clause 15.12 (Notices)
(c) Any other method permitted by applicable law

**16.7 Enforcement**

Any judgment or arbitral award obtained in connection with this Agreement may be enforced in any court of competent jurisdiction in Nigeria, the United Kingdom, or any other country.

---

## 17. SPECIAL PROVISIONS FOR HEALTHCARE COMPLIANCE

**17.1 National Health Act Compliance (Nigeria)**

The Parties acknowledge and agree that where Confidential Information includes patient health information or relates to healthcare services in Nigeria, they shall comply with:

(a) Section 44 of the National Health Act 2014, which provides that all information concerning a user's health status, treatment, or stay in a health establishment is confidential
(b) The duty of healthcare professionals to maintain patient confidentiality
(c) Requirements for secure storage and handling of health facility records

**17.2 Clinical Governance**

Where the Receiving Party is a healthcare professional or provides healthcare-related services, the Receiving Party shall:

(a) Maintain appropriate professional indemnity insurance
(b) Comply with applicable professional codes of conduct and ethics
(c) Ensure that all advice, diagnosis, and treatment provided through the Platform meets accepted medical standards
(d) Implement clinical governance frameworks to ensure patient safety

**17.3 NAFDAC Compliance**

Where Confidential Information includes pharmaceutical or drug-related information, particularly the NAFDAC drug verification database, the Receiving Party shall:

(a) Use such information solely for legitimate healthcare and patient safety purposes
(b) Not manipulate, alter, or misrepresent NAFDAC verification data
(c) Comply with all NAFDAC regulations and guidelines
(d) Report any suspected counterfeit medications to NAFDAC and appropriate authorities

**17.4 Emergency Override**

Notwithstanding any other provision of this Agreement, where disclosure of Health Information is necessary to:
(a) Prevent or lessen a serious threat to the life, health, or safety of an individual or the public
(b) Comply with mandatory reporting requirements for infectious diseases, child protection, or other public health purposes
(c) Assist in disaster management or emergency response

The Receiving Party may disclose such information to the extent necessary for such purpose, provided that the Receiving Party:
- Limits disclosure to the minimum necessary
- Notifies the Disclosing Party as soon as practicable
- Documents the disclosure and the justification

---

## 18. REGULATORY COMPLIANCE AND REPORTING

**18.1 Nigeria Data Protection Commission (NDPC)**

The Parties acknowledge the jurisdiction of the Nigeria Data Protection Commission and agree to:

(a) Register as a Data Controller or Data Processor as required by NDPA 2023
(b) Appoint a Data Protection Officer if required
(c) Conduct Data Protection Impact Assessments (DPIAs) for high-risk processing
(d) Maintain records of processing activities
(e) Cooperate with NDPC audits and investigations
(f) Report data breaches to NDPC within 72 hours where required

**18.2 UK Information Commissioner's Office (ICO)**

Where the Receiving Party processes Personal Data of UK residents or operates in the UK, it shall:

(a) Register with the ICO as a Data Controller or Data Processor as required
(b) Pay applicable data protection fees
(c) Comply with ICO codes of practice and guidance
(d) Respond promptly to ICO inquiries and investigations
(e) Report data breaches to ICO within 72 hours where required

**18.3 Other Regulatory Bodies**

The Parties shall comply with requirements of other relevant regulatory bodies, including but not limited to:
- Federal Ministry of Health (Nigeria)
- State Ministries of Health
- Medical and Dental Council of Nigeria (MDCN)
- Pharmacists Council of Nigeria (PCN)
- Nursing and Midwifery Council of Nigeria (NMCN)
- National Health Insurance Authority (NHIA)
- Care Quality Commission (UK)
- General Medical Council (UK)
- Nursing and Midwifery Council (UK)

**18.4 Regulatory Reporting**

If the Receiving Party becomes aware of any:
(a) Regulatory investigation or inquiry involving the Confidential Information
(b) Request for information from a regulatory body
(c) Regulatory breach or non-compliance

It shall notify the Disclosing Party immediately and cooperate in responding to such matters.

---

## 19. ACKNOWLEDGMENTS AND REPRESENTATIONS

**19.1** The Receiving Party acknowledges and represents that:

(a) It has carefully read and fully understands all provisions of this Agreement
(b) It has had the opportunity to seek independent legal advice
(c) It enters into this Agreement freely and voluntarily
(d) It has the full power, authority, and capacity to enter into and perform this Agreement
(e) This Agreement constitutes a legal, valid, and binding obligation enforceable against it
(f) The execution and performance of this Agreement does not violate any other agreement, law, or regulation to which it is bound
(g) It understands the serious nature of its confidentiality obligations and the consequences of breach

**19.2** Where the Receiving Party is an individual, they further acknowledge and represent that:

(a) They are at least 18 years of age
(b) They are of sound mind and legal capacity
(c) They have not been declared bankrupt or of unsound mind by any court

**19.3** Where the Receiving Party is a corporate entity, it further represents and warrants that:

(a) It is duly organized, validly existing, and in good standing under the laws of its jurisdiction of incorporation
(b) It is duly registered to do business in Nigeria and/or the UK as applicable
(c) The signatory has full authority to bind the entity to this Agreement
(d) All necessary corporate approvals have been obtained

---

## 20. EXECUTION AND WITNESSING

**20.1 Execution**

This Agreement must be executed by authorized signatories of both Parties in the presence of witnesses as required by Nigerian law.

**20.2 Witnessing Requirements**

Each Party's signature shall be witnessed by at least one (1) competent witness who:
(a) Is at least 18 years of age
(b) Is of sound mind
(c) Is not a party to this Agreement
(d) Has personal knowledge of the signatory's identity

---

## SCHEDULE 1: SPECIFIC PURPOSE AND SCOPE

[*To be completed based on the specific relationship. Examples below:*]

**1. Purpose of Disclosure:**

The Confidential Information is being disclosed for the following specific purpose(s):

☐ **Employment/Engagement:** The Receiving Party is being employed/engaged as _____________ [Job Title/Role] and requires access to Confidential Information to perform their duties.

☐ **Partnership Evaluation:** The Parties are exploring a potential business partnership relating to _____________.

☐ **Investment Due Diligence:** The Receiving Party is evaluating a potential investment in the Company and requires access to business and financial information.

☐ **Service Provider:** The Receiving Party is providing _____________ [specific services] to the Company.

☐ **Technology Development:** Joint development of _____________ [specific technology or feature].

☐ **Research Collaboration:** Collaborative research on _____________ [specific research area].

☐ **Other:** _____________ [Please specify]

**2. Scope of Confidential Information:**

The following categories of Confidential Information may be disclosed (tick all that apply):

☐ Business plans and strategies
☐ Financial information and projections
☐ Technical specifications and source code
☐ AI algorithms and models
☐ Patient data and health records
☐ Provider network information
☐ Marketing and user data
☐ Intellectual property documentation
☐ Partnership and supplier agreements
☐ Other: _____________

**3. Permitted Disclosures:**

The Receiving Party may disclose Confidential Information to the following Representatives (if applicable):

☐ Employees in _____________ department(s)
☐ Board members and advisors
☐ External legal counsel
☐ External auditors and accountants
☐ Potential investors (subject to separate NDA)
☐ Technology consultants (subject to separate NDA)
☐ Other: _____________

**4. Specific Restrictions:**

In addition to the general restrictions in this Agreement, the following specific restrictions apply:

☐ No use of AI/ML models for training other systems
☐ No reverse engineering of software
☐ No disclosure to competitors
☐ No public announcements without approval
☐ No contact with patients or healthcare providers without approval
☐ Other: _____________

---

## SCHEDULE 2: DATA PROTECTION ANNEX

**1. Categories of Data Subjects:**

☐ Patients and healthcare users
☐ Healthcare professionals (doctors, nurses, etc.)
☐ Clinic and hospital staff
☐ Employees of the Company
☐ Business partners and service providers
☐ Other: _____________

**2. Types of Personal Data:**

☐ Basic identity information (name, age, gender)
☐ Contact information (address, phone, email)
☐ Health data (medical history, diagnoses, treatments)
☐ Biometric data
☐ Genetic data
☐ Mental health information
☐ Financial information
☐ Employment information
☐ Location data
☐ Other: _____________

**3. Special Category/Sensitive Data:**

☐ Health information
☐ Racial or ethnic origin
☐ Religious or philosophical beliefs
☐ Trade union membership
☐ Genetic data
☐ Biometric data
☐ Sexual orientation
☐ Criminal convictions or offenses

**4. Processing Operations:**

☐ Collection
☐ Storage
☐ Analysis
☐ Sharing/Disclosure
☐ Transmission
☐ Deletion/Destruction
☐ Other: _____________

**5. Data Retention Period:**

Personal Data shall be retained for: ☐ Duration of relationship + 7 years
                                   ☐ Duration of relationship + 10 years
                                   ☐ As required by law
                                   ☐ Other: _____________

**6. Technical and Organizational Measures:**

The Receiving Party has implemented the following security measures:

☐ Encryption (in transit and at rest)
☐ Access controls and authentication
☐ Firewall and network security
☐ Regular security audits
☐ Staff training on data protection
☐ Incident response procedures
☐ Data backup and recovery systems
☐ Physical access controls
☐ Other: _____________

**7. Sub-Processors (if applicable):**

The Receiving Party may engage the following sub-processors:

Name: _____________
Address: _____________
Services: _____________
Security Measures: _____________

**8. Cross-Border Transfers:**

☐ Personal Data will NOT be transferred outside Nigeria/UK
☐ Personal Data may be transferred to: _____________ [Country]
   Using the following safeguards: ☐ Standard Contractual Clauses
                                   ☐ Adequacy Decision
                                   ☐ Binding Corporate Rules
                                   ☐ Other: _____________

---

## SCHEDULE 3: CONTACTS AND KEY PERSONNEL

**For the Company (Disclosing Party):**

**Primary Contact:**
Name: _____________
Title: _____________
Email: _____________
Phone: _____________

**Data Protection Officer:**
Name: _____________
Email: _____________
Phone: _____________

**Legal/Compliance Contact:**
Name: _____________
Email: _____________
Phone: _____________

**For the Receiving Party:**

**Primary Contact:**
Name: _____________
Title: _____________
Email: _____________
Phone: _____________

**Data Protection Officer (if applicable):**
Name: _____________
Email: _____________
Phone: _____________

**Legal/Compliance Contact:**
Name: _____________
Email: _____________
Phone: _____________

---

## SIGNATURES

**IN WITNESS WHEREOF**, the Parties have executed this Agreement as of the date first written above.

---

**FOR AND ON BEHALF OF CAREMATCH AI LIMITED (Disclosing Party):**

**Signed:** _________________________________

**Name:** _________________________________

**Title:** _________________________________

**Date:** _________________________________

**WITNESSED BY:**

**Witness Signature:** _________________________________

**Witness Name:** _________________________________

**Witness Address:** _________________________________

**Witness Occupation:** _________________________________

**Date:** _________________________________

---

**FOR AND ON BEHALF OF [RECEIVING PARTY NAME]:**

**Signed:** _________________________________

**Name:** _________________________________

**Title (if applicable):** _________________________________

**Date:** _________________________________

**WITNESSED BY:**

**Witness Signature:** _________________________________

**Witness Name:** _________________________________

**Witness Address:** _________________________________

**Witness Occupation:** _________________________________

**Date:** _________________________________

---

## ANNEX A: DEFINITIONS OF APPLICABLE LAWS

**1. Nigeria Data Protection Act (NDPA) 2023**
The principal legislation governing data protection in Nigeria, which repealed and replaced the Nigeria Data Protection Regulation (NDPR) 2019.

**2. National Health Act 2014**
Nigerian legislation governing the health system and establishing the framework for patient rights, including confidentiality of health information.

**3. UK General Data Protection Regulation (UK GDPR)**
The UK's implementation of the EU GDPR following Brexit, governing the processing of personal data in the UK.

**4. Data Protection Act 2018 (UK)**
UK legislation that supplements the UK GDPR and provides additional data protection provisions.

**5. Evidence Act 2011 (Nigeria)**
Governs the admissibility of evidence, including written contracts, in Nigerian courts.

**6. Companies and Allied Matters Act (CAMA) 2020**
Principal legislation governing companies and business entities in Nigeria.

---

## ANNEX B: GLOSSARY OF HEALTHCARE TERMS

**NAFDAC:** National Agency for Food and Drug Administration and Control - Nigerian regulatory agency responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, chemicals, and packaged water.

**Health Facility:** Any facility established for the provision of health services, including hospitals, clinics, maternity homes, health centers, and dispensaries.

**Healthcare Professional:** A person registered and licensed to practice any health profession, including doctors, nurses, pharmacists, and allied health professionals.

**Patient:** A person receiving or registered to receive healthcare services.

**Health Record:** A record containing information relating to the physical or mental health of an individual, including:
- Information about past, present, or future health status
- Provision of healthcare to the individual
- Genetic information

**Clinical Governance:** A framework through which healthcare organizations are accountable for continuously improving the quality of their services and safeguarding high standards of care.

---

## ANNEX C: BREACH NOTIFICATION TEMPLATE

**TO BE USED IN THE EVENT OF A DATA BREACH**

**Date of Notification:** _____________

**From:** [Receiving Party Name]

**To:** [Disclosing Party Name / Data Protection Officer]

**RE: DATA BREACH NOTIFICATION**

**1. Nature of the Breach:**
Description: _____________
Date/Time Discovered: _____________
Date/Time Occurred: _____________

**2. Categories and Number of Data Subjects Affected:**
_____________

**3. Categories and Number of Personal Data Records Concerned:**
_____________

**4. Type of Confidential Information Involved:**
☐ Patient Health Information
☐ Technical/Proprietary Information
☐ Business Information
☐ Financial Information  
☐ Other: _____________

**5. Likely Consequences of the Breach:**
_____________

**6. Measures Taken or Proposed to Address the Breach:**
_____________

**7. Measures Taken or Proposed to Mitigate Adverse Effects:**
_____________

**8. Contact Person for Further Information:**
Name: _____________
Email: _____________
Phone: _____________

**Signature:** _____________
**Date:** _____________

---

**END OF AGREEMENT**

---

**IMPORTANT NOTICES:**

**1. LEGAL REVIEW REQUIRED:** This document is a comprehensive template. Before execution, both parties should have it reviewed by qualified legal counsel in both Nigeria and the United Kingdom to ensure it meets specific needs and complies with current laws.

**2. CUSTOMIZATION REQUIRED:** Schedules and certain provisions marked with brackets [ ] or checkboxes ☐ must be completed before execution.

**3. REGULATORY COMPLIANCE:** Ensure all regulatory registrations (NDPC, ICO, etc.) are current before executing this agreement.

**4. DATA PROTECTION IMPACT ASSESSMENT:** Consider conducting a DPIA before processing high-risk personal data.

**5. INSURANCE:** Consider obtaining cyber insurance and professional indemnity insurance to cover potential liabilities.

**6. UPDATES:** This agreement should be reviewed and updated regularly to reflect changes in law, particularly data protection legislation which evolves rapidly.

---

**Document Version:** 1.0  
**Last Updated:** December 3, 2025  
**Prepared For:** CareMatch AI Limited  
**Compliance:** Nigerian Law & UK Law
